Probing relationships between DNA methylation and cellular senescence with high-throughput CRISPR-based epigenetic editing
利用基于 CRISPR 的高通量表观遗传编辑探索 DNA 甲基化与细胞衰老之间的关系
基本信息
- 批准号:10593233
- 负责人:
- 金额:$ 19.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-12-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AccelerationActive SitesAddressAffectAgeAgingAutomobile DrivingBiologicalBiological ProcessBiologyCRISPR screenCRISPR/Cas technologyCell AgingCell physiologyCellsClustered Regularly Interspaced Short Palindromic RepeatsCoupledDNADNA MethylationDataDepositionDiseaseElementsEngineeringEpigenetic ProcessExhibitsFrequenciesFutureGene ExpressionGene SilencingGenomeGenomicsGoldGuide RNAHealthHumanIn VitroIndividualInflammationLibrariesLinkMesenchymal Stem CellsMethodologyMethodsMethylationModelingModificationMolecular ConformationMorphologyOrganismOutcomeOutputPhenotypePlayPopulationProcessProliferatingProteinsPublishingRNA libraryRoleSignal InductionSiteSortingSpecific qualifier valueSystemTechniquesTechnologyTestingTissuesUntranslated RNAValidationWorkWritingagedbisulfite sequencingcell agecell behaviorcell typecellular developmentcellular engineeringcombinatorialepigenomeepigenomicsgenome-widegenomic locushigh throughput screeninginsightinterestmethylomenext generation sequencingnucleaseresponsesenescencestandard measuretechnology platformtooltranscriptome sequencingwhole genome
项目摘要
ABSTRACT
Cellular senescence is a phenomenon associated with aging, wherein cells stop proliferating and secrete
factors which may impact the function of surrounding cells and tissues. Although epigenetic readouts, and in
particular DNA methylation (CpGme), have found to be associated with aging and cellular senescence, it remains
undetermined whether accumulated changes in CpGme are merely correlated with senescence or whether they
play a causal role in driving it. To answer this question, we will combine next-generation sequencing techniques
along with CRISPR-based CpGme editing and CRISPR screens to elucidate the causative associations between
CpGme sites across the genome and cellular senescence.
In Aim 1, we will assess CpGme sites of interest for effect on cellular senescence with a high-throughput
CRISPR screen. Using a CRISPR molecule capable of depositing CpGme, it is possible to generate a population
of cells, each with CpGme modified at a particular site. By characterizing how these CpGme modifications
influence the entry rate into senescence, we will identify CpGme sites that causally affect senescence.
In Aim 2, we will dissect how the most active sites operate to affect senescence. This will be done by inducing
CpGme at the target sites and observing how this influences genomic CpGme and gene expression profiles,
which will provide mechanistic understanding of how the perturbations we make affect cellular function. We will
develop methods to more broadly apply CpGme editing to control cellular senescence. The work will illuminate
an important process associated with aging and will provide new tools to for understanding how epigenetics
impacts biological function, as well as how we can engineer cells to optimize health in the future.
抽象的
细胞衰老是一种与衰老相关的现象,其中细胞停止增殖和分泌
影响周围细胞和组织功能的因素。尽管表观遗传读数,并且在
特定的 DNA 甲基化 (CpGme) 已被发现与衰老和细胞衰老有关,但它仍然存在
尚未确定 CpGme 的累积变化是否仅与衰老相关,或者是否与衰老相关
对其起到因果作用。为了回答这个问题,我们将结合下一代测序技术
以及基于 CRISPR 的 CpGme 编辑和 CRISPR 筛选,以阐明之间的因果关系
跨基因组和细胞衰老的 CpGme 位点。
在目标 1 中,我们将通过高通量评估感兴趣的 CpGme 位点对细胞衰老的影响。
CRISPR 筛选。使用能够沉积 CpGme 的 CRISPR 分子,可以产生群体
细胞,每个细胞的特定位点都经过 CpGme 修饰。通过表征这些 CpGme 修饰的方式
影响进入衰老的速度,我们将确定因果影响衰老的 CpGme 位点。
在目标 2 中,我们将剖析最活跃的位点如何影响衰老。这将通过诱导来完成
目标位点的 CpGme 并观察这如何影响基因组 CpGme 和基因表达谱,
这将从机制上理解我们所做的扰动如何影响细胞功能。我们将
开发更广泛地应用 CpGme 编辑来控制细胞衰老的方法。工作将会照亮
与衰老相关的重要过程,将为理解表观遗传学如何提供新工具
影响生物功能,以及我们如何改造细胞以优化未来的健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lei Stanley Qi其他文献
Lei Stanley Qi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lei Stanley Qi', 18)}}的其他基金
Development of multi-color 3D super-localization LiveFISH and LiveFISH PAINT to investigate the chromatin dynamics at any genomic scale
开发多色 3D 超定位 LiveFISH 和 LiveFISH PAINT,以研究任何基因组规模的染色质动态
- 批准号:
10725002 - 财政年份:2023
- 资助金额:
$ 19.38万 - 项目类别:
Manipulating and Interrogating Spatial Transcriptomics
操纵和询问空间转录组学
- 批准号:
10702050 - 财政年份:2023
- 资助金额:
$ 19.38万 - 项目类别:
A Cas13d-based screening approach to engineer exhaustion-resistant CAR T cells
基于 Cas13d 的筛选方法来设计抗耗竭 CAR T 细胞
- 批准号:
10431227 - 财政年份:2022
- 资助金额:
$ 19.38万 - 项目类别:
A Cas13d-based screening approach to engineer exhaustion-resistant CAR T cells
基于 Cas13d 的筛选方法来设计抗耗竭 CAR T 细胞
- 批准号:
10571868 - 财政年份:2022
- 资助金额:
$ 19.38万 - 项目类别:
High resolution dissection of oncogene enhancer networks via CRISPR screening and live-cell imaging.
通过 CRISPR 筛选和活细胞成像对癌基因增强子网络进行高分辨率解剖。
- 批准号:
10522013 - 财政年份:2022
- 资助金额:
$ 19.38万 - 项目类别:
High resolution dissection of oncogene enhancer networks via CRISPR screening and live-cell imaging.
通过 CRISPR 筛选和活细胞成像对癌基因增强子网络进行高分辨率解剖。
- 批准号:
10671756 - 财政年份:2022
- 资助金额:
$ 19.38万 - 项目类别:
Examining COVID-19 in Down Syndrome Patients Using Human iPSC-Derived Organoids
使用人类 iPSC 衍生的类器官检查唐氏综合症患者的 COVID-19
- 批准号:
10241207 - 财政年份:2021
- 资助金额:
$ 19.38万 - 项目类别:
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs
使用人 iPSC 模拟酪氨酸激酶抑制剂诱导的血管功能障碍
- 批准号:
10518663 - 财政年份:2018
- 资助金额:
$ 19.38万 - 项目类别:
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in DCM - Diversity Supplement
人类 iPSC 用于阐明 DCM 中的细胞间串扰信号传导 - 多样性补充
- 批准号:
10730997 - 财政年份:2018
- 资助金额:
$ 19.38万 - 项目类别:
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy
人类 iPSC 用于阐明扩张型心肌病中的细胞间串扰信号传导
- 批准号:
10852761 - 财政年份:2018
- 资助金额:
$ 19.38万 - 项目类别:
相似海外基金
Development of Selective Oxidative Biocatalytic Methods
选择性氧化生物催化方法的发展
- 批准号:
10606798 - 财政年份:2023
- 资助金额:
$ 19.38万 - 项目类别:
Research and cloud deployment of enhanced sampling methods in MovableType
MovableType中增强采样方法的研究和云部署
- 批准号:
10699159 - 财政年份:2023
- 资助金额:
$ 19.38万 - 项目类别:
PAIRS: Validating telomerase reverse transcriptase (TERT) as an intrinsic vulnerability toward sensitizing cancer to radiation
配对:验证端粒酶逆转录酶 (TERT) 作为癌症对辐射敏感的内在脆弱性
- 批准号:
10718390 - 财政年份:2023
- 资助金额:
$ 19.38万 - 项目类别:
Development of small molecule inhibitors of metabolic enzymes as broad spectrum anthelmintic drugs
开发小分子代谢酶抑制剂作为广谱驱虫药
- 批准号:
10581534 - 财政年份:2021
- 资助金额:
$ 19.38万 - 项目类别:
Development of a Mechanism and Structure-Guided Methodology for De Novo Enzyme Design
开发从头酶设计的机制和结构引导方法
- 批准号:
10231920 - 财政年份:2021
- 资助金额:
$ 19.38万 - 项目类别: